ImmunoPrecise Antibodies Newsroom

Positive Sentiment Still Eludes ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Following 30% Share Price Slump

Simply Wall StNov 23 07:43 ET

ImmunoPrecise Antibodies Advances in Cancer Therapy Development

TipRanksNov 13 09:48 ET

$20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer Therapies

Business WireNov 13 09:00 ET

ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation

BusinesswireNov 4 08:01 ET

Express News | ImmunoPrecise Highlights Publication Of Mayo Clinic Scientist-Led Research In BioRxiv And Autophagy Titled 'Development and Characterization of Phospho-Ubiquitin Antibodies to Monitor PINK1-PRKN Signaling in Cells and Tissue'

BenzingaOct 28 07:32 ET

ImmunoPrecise Advances Anti-Aging Research With Mayo Clinic Study, Poised to Tap Into $81 Billion Market With AI Technology

BusinesswireOct 28 07:30 ET

ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024

BusinesswireOct 21 09:00 ET

ImmunoPrecise Sets Virtual AGM for November 2024

TipRanksOct 11 15:47 ET

ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design

BusinesswireOct 10 08:10 ET

Express News | Immunoprecise Antibodies Ltd - Biotheus to Evaluate Talem's AI-Enhanced Tatx-20 for Bispecific Antibodies

ReutersOct 2 08:03 ET

Express News | Immunoprecise Subsidiary Signs Material Transfer Agreement With Biotheus

ReutersOct 2 08:00 ET

ImmunoPrecise Antibodies Advances Therapeutic Innovation With Rabbit Antibody Developments, Says Rabbit B Cell Select Drives Clinical Breakthroughs In Cancer Treatment

BenzingaSep 26 09:16 ET

Express News | Immunoprecise Antibodies Advances Therapeutic Innovation With Groundbreaking Rabbit Antibody Developments

ReutersSep 26 09:03 ET

Press Release: Institute for Portfolio Alternatives Announces 2025 Board of Directors

Dow JonesSep 25 16:22 ET

ImmunoPrecise Antibodies Price Target Maintained With a $9.00/Share by HC Wainwright & Co.

Dow JonesSep 17 07:48 ET · Ratings

ImmunoPrecise Antibodies Analyst Ratings

BenzingaSep 17 07:37 ET · Ratings

Maintained Buy Rating for ImmunoPrecise Antibodies on Strong Revenue and Strategic Growth Prospects

TipRanksSep 17 06:15 ET · Ratings

ImmunoPrecise Antibodies Ltd. (IPA) Q1 2025 Earnings Call Transcript Summary

moomoo AISep 16 14:05 ET · Conference Call

ImmunoPrecise Antibodies Ltd. (IPA) Q1 2025 Earnings Call Transcript

Earnings Call TranscriptsSep 16 13:46 ET

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q1 Loss, Misses Revenue Estimates

Zacks Sep 16 09:30 ET